Valuation: Bionime Corporation

Market Cap 431.49Cr 13Cr 12Cr 11Cr 9.85Cr 19Cr 1.24TCr 19Cr 130.03Cr 52Cr 660.12Cr 49Cr 48Cr 2.08TCr P/E 2024
-31x
P/E 2025 -22.2x
Enterprise Value 688.86Cr 21Cr 19Cr 17Cr 16Cr 30Cr 1.98TCr 31Cr 207.59Cr 83Cr 1.05TCr 79Cr 77Cr 3.33TCr EV / Sales 2024
3.48x
EV / Sales 2025 3.58x
Free-Float
43.34%
Yield 2024 *
-
Yield 2025 -
1 day-0.36%
1 week-14.94%
Current month-14.94%
1 month+1.45%
3 months+1.45%
6 months-5.10%
Current year-6.22%
1 week 50.6
Extreme 50.6
59.4
1 month 50.6
Extreme 50.6
65.6
Current year 49.75
Extreme 49.75
72.9
1 year 49.75
Extreme 49.75
72.9
3 years 43.14
Extreme 43.14154
73.9
5 years 43.14
Extreme 43.14154
88.92
10 years 41.87
Extreme 41.86866
88.92
Manager TitleAgeSince
Chief Executive Officer - 09/07/2010
Director of Finance/CFO - 06/11/2017
Chief Tech/Sci/R&D Officer - 07/11/2018
Director TitleAgeSince
Chairman - 14/04/2003
Director/Board Member - 17/10/2007
Director/Board Member - 28/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-14.94%-12.95%-23.28% 13Cr
-3.23%+3.51%-13.00%+16.03% 19TCr
-2.90%+5.45%+10.41%+41.96% 12TCr
-2.75%+11.65%-8.47%+18.59% 12TCr
+0.96%+5.15%-37.16%+11.38% 9.93TCr
-1.80%+0.82%-7.52%+69.50% 6.37TCr
-0.78%+7.07%+19.14%-17.21% 5.77TCr
+0.79%+22.65%-4.57%+58.05% 5.33TCr
+3.22%-6.72%-7.56%+48.14% 4.7TCr
-2.36%+3.72%+3.86%-7.32% 3.62TCr
Average -0.92%+3.99%-5.78%+21.59% 7.96TCr
Weighted average by Cap. -1.60%+5.55%-7.23%+25.41%

Financials

2024 2025
Net sales 193.37Cr 5.9Cr 5.29Cr 4.83Cr 4.41Cr 8.31Cr 554.43Cr 8.58Cr 58Cr 23Cr 295.83Cr 22Cr 22Cr 933.92Cr 183.86Cr 5.61Cr 5.03Cr 4.6Cr 4.2Cr 7.91Cr 527.15Cr 8.15Cr 55Cr 22Cr 281.28Cr 21Cr 21Cr 887.96Cr
Net income -13Cr -38.8L -34.8L -31.81L -29.03L -54.7L -36Cr -56.43L -3.83Cr -1.53Cr -19Cr -1.46Cr -1.43Cr -61Cr -18Cr -54.99L -49.32L -45.07L -41.14L -77.52L -52Cr -79.96L -5.43Cr -2.17Cr -28Cr -2.06Cr -2.02Cr -87Cr
Net Debt 278.4Cr 8.49Cr 7.62Cr 6.96Cr 6.35Cr 12Cr 798.21Cr 12Cr 84Cr 33Cr 425.91Cr 32Cr 31Cr 1.34TCr 257.37Cr 7.85Cr 7.04Cr 6.43Cr 5.87Cr 11Cr 737.91Cr 11Cr 78Cr 31Cr 393.73Cr 29Cr 29Cr 1.24TCr
Projected Income Statement - Annual - Bionime Corporation
Logo Bionime Corporation
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
Employees
-
Date Price Change Volume
06/26/06 NT$55.80 -0.36% 89,321
05/26/05 NT$56.00 -1.58% 45,481
04/26/04 NT$56.90 -2.57% 98,599
03/26/03 NT$58.40 -1.18% 93,788
02/26/02 NT$59.10 -9.91% 2,57,441

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Bionime Corporation
  1. Stock Market
  2. Stocks
  3. 4737 Stock